Bone Research
Bone Metastases Therapeutics - Strong Pipeline is Likely to Result in Steep Growth for the Market
Published in Clinical Trials Week, May 30th, 2011
2011 MAY 30 -- Research and Markets has announced the addition of GlobalData's new report "Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017" to their offering. Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017 report is an essential source of information and analysis on the global bone metastases therapeutics market. The report identifies the key trends shaping and driving the global bone metastases therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2011-05-30)
More Articles from Clinical Trials Week
- Clinical Trials Research
ACT Announces Oregon Health & Science University as Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration - Clinical Trials Research
Accelr8 Announces Initial Results from ICU Pilot Clinical Study for Same-Day, Multi-Organism, Multi-Resistance Diagnostics Presented at ATS - Research and Markets
Acute Upper Respiratory Infections AURI Therapeutics - Strong Market Includes Therapies that have Increased the AURI Market - Alnylam Pharmaceuticals, Inc.
Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncology ASCO - Celiac Disease
Alvine Pharmaceuticals Announces Issuance of US Patents for Enzyme Use in Celiac Disease - University of Mississippi Medical Center
Anti-cancer drug discovery partnership formed between UMMC and Ole Miss - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
